Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 760 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 760 · Balance 760 F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2: Annual non-employee director award. F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. F4: Not applicable as restricted stock units do not have an expiration date. |
| Common StockSEC Table I · non-derivative | Direct | 21,884 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 21,884 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2: Annual non-employee director award.
F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
F4: Not applicable as restricted stock units do not have an expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 23, 2026 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 760 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001460472-26-000002 · primarydocument.xml · derivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760 Underlying: Common Stock · 760 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,310 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001460472-26-000001 · primarydocument.xml · derivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001460472-26-000001 · primarydocument.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:24 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005525 · primarydocument.xml · derivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:24 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005525 · primarydocument.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:24 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,310 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005525 · primarydocument.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,310 Underlying: Common Stock · 1,310 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| June 24, 2025 Filed Jun 25, 2025 20:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001562180-25-005065 · primarydocument.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2025 Filed Jun 25, 2025 20:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 3,036 | $289.60 | $879,214.06 |
DisclosureSEC source: 0001562180-25-005065 · primarydocument.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,384 F1 · kind: Exercise of stock options in a cashless sell-to-cover transaction, where a sufficient number of shares was sold to cover the exercise price. Read SEC document |
| June 24, 2025 Filed Jun 25, 2025 20:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $175.43 | $877,150.00 |
DisclosureSEC source: 0001562180-25-005065 · primarydocument.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2024 Filed Nov 6, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 10,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-24-026241 · form4-11062024_041101.xml · derivative · entry 4 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 10,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2024 Filed Nov 6, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,429 | $382.28 | $546,272.69 |
DisclosureSEC source: 0001415889-24-026241 · form4-11062024_041101.xml · nonDerivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,420 F2 · price: This transaction was executed in multiple trades at prices ranging from $382.13 to $382.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2024 Filed Nov 6, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 8,571 | $381.61 | $3,270,749.31 |
DisclosureSEC source: 0001415889-24-026241 · form4-11062024_041101.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,849 F1 · price: This transaction was executed in multiple trades at prices ranging from $381.08 to $382.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2024 Filed Nov 6, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 10,000 | $175.43 | $1,754,300.00 |
DisclosureSEC source: 0001415889-24-026241 · form4-11062024_041101.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020173 · form4-07262024_040728.xml · derivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,190 Underlying: Common Stock · 1,190 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 13, 2024 Filed Jul 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019547 · form4-07152024_040701.xml · derivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 13, 2024 Filed Jul 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019547 · form4-07152024_040701.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 10,000 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001415889-24-007187 · form4-03072024_040313.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 10,000 | $236.97 | $2,369,700.00 |
DisclosureSEC source: 0001415889-24-007187 · form4-03072024_040313.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,620 F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 10,000 | $88.03 | $880,300.00 |
DisclosureSEC source: 0001415889-24-007187 · form4-03072024_040313.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001415889-23-015743 · form4-12042023_041202.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 500 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 5,000 | $240.73 | $1,203,650.00 |
DisclosureSEC source: 0001415889-23-015743 · form4-12042023_041202.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,620 F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $88.03 | $440,150.00 |
DisclosureSEC source: 0001415889-23-015743 · form4-12042023_041202.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 10:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011157 · form4-07172023_060720.xml · derivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 07, 2023 Filed Jul 7, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010947 · form4-07072023_040705.xml · derivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 07, 2023 Filed Jul 7, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010947 · form4-07072023_040705.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001415889-23-008608 · form4-05232023_040501.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 5,000 | $218.59 | $1,092,950.00 |
DisclosureSEC source: 0001415889-23-008608 · form4-05232023_040501.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,870 F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $63.90 | $319,500.00 |
DisclosureSEC source: 0001415889-23-008608 · form4-05232023_040501.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 10,000 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0001415889-22-011503 · form4-11172022_041117.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 10,000 shares Expires 2023-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These particular share tracking awards were approaching the end of their 10-year term on June 26, 2023. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 10,000 | $261.05 | $2,610,500.00 |
DisclosureSEC source: 0001415889-22-011503 · form4-11172022_041117.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,870 F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These particular share tracking awards were approaching the end of their 10-year term on June 26, 2023. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 10,000 | $63.90 | $639,000.00 |
DisclosureSEC source: 0001415889-22-011503 · form4-11172022_041117.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These particular share tracking awards were approaching the end of their 10-year term on June 26, 2023. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 21:52 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 2,160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007610 · form4-07082022_020736.xml · derivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 21:52 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon | 2,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007610 · form4-07082022_020736.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 21:52 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007610 · form4-07082022_020736.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 20:51 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 2,160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-021760 · form4.xml · derivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,160 Underlying: Common Stock · 2,160 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Units · Derivative | 3,360 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020801 · form4.xml · derivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020801 · form4.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock united on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 10,000 | $0.00 Strike: $48.11 | $0.00 |
DisclosureSEC source: 0001127602-21-001269 · form4.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 10,000 | $163.51 | $1,635,100.00 |
DisclosureSEC source: 0001127602-21-001269 · form4.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,350 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:36 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 10,000 | $48.11 | $481,100.00 |
DisclosureSEC source: 0001127602-21-001269 · form4.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:35 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $48.11 | $0.00 |
DisclosureSEC source: 0001127602-21-001000 · form4.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2022-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:35 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 5,000 | $156.77 | $783,850.00 |
DisclosureSEC source: 0001127602-21-001000 · form4.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,350 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:35 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $48.11 | $240,550.00 |
DisclosureSEC source: 0001127602-21-001000 · form4.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 04, 2021 Filed Apr 16, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-21-013885 · form4.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 04, 2021 Filed Apr 16, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 5,000 | $153.94 | $769,700.00 |
DisclosureSEC source: 0001127602-21-013885 · form4.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,350 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 04, 2021 Filed Apr 16, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $54.77 | $273,850.00 |
DisclosureSEC source: 0001127602-21-013885 · form4.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 21:56 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-20-031996 · form4.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 21:56 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 5,000 | $148.44 | $742,200.00 |
DisclosureSEC source: 0001127602-20-031996 · form4.xml · nonDerivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,350 F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 21:56 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $54.77 | $273,850.00 |
DisclosureSEC source: 0001127602-20-031996 · form4.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 04, 2020 Filed Nov 5, 2020 21:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $54.77 | $0.00 |
DisclosureSEC source: 0001127602-20-028241 · form4.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2021-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.